Qingdao Oushijian Digital Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Qingdao Oushijian Digital Technology Co., Ltd holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AUROVIX, ZENIVOR, and ESSOVITA. The owner is based in Qingdao.
No. 1 Guantao Road, Shibei District
Building 1, 101-17
Qingdao 221000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Qingdao Oushijian Digital Technology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Qingdao Oushijian Digital Technology Co., Ltd have?
Qingdao Oushijian Digital Technology Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Qingdao Oushijian Digital Technology Co., Ltd file in?
Qingdao Oushijian Digital Technology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Qingdao Oushijian Digital Technology Co., Ltd's most well-known trademarks?
Qingdao Oushijian Digital Technology Co., Ltd's registered trademark portfolio includes well-known marks such as AUROVIX, ZENIVOR, and ESSOVITA. These are among 3 currently registered trademarks in the portfolio.
What is Qingdao Oushijian Digital Technology Co., Ltd's trademark registration success rate?
Qingdao Oushijian Digital Technology Co., Ltd has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.